标题
Role of the ubiquitin proteasome system in hematologic malignancies
作者
关键词
-
出版物
IMMUNOLOGICAL REVIEWS
Volume 263, Issue 1, Pages 224-239
出版商
Wiley
发表日期
2014-12-15
DOI
10.1111/imr.12236
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A High Occurrence of Acquisition and/or Expansion of C-CBL Mutant Clones in the Progression of High-Risk Myelodysplastic Syndrome to Acute Myeloid Leukemia
- (2015) Hsiao-Wen Kao et al. NEOPLASIA
- Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I)
- (2014) Zhenghong Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
- (2014) Y. Gu et al. BLOOD
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- Notch signaling: switching an oncogene to a tumor suppressor
- (2014) C. Lobry et al. BLOOD
- Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
- (2014) P. G. Richardson et al. BLOOD
- CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration
- (2014) dengwen li et al. CELL CYCLE
- NF-κB pathways in hematological malignancies
- (2014) Chiara Gasparini et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
- (2014) Lihua Zhu et al. Hematology
- The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer
- (2014) Markus E. Diefenbacher et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
- (2013) Florian Bassermann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- EZH2 mutations are frequent and represent an early event in follicular lymphoma
- (2013) C. Bodor et al. BLOOD
- The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
- (2013) B. Meissner et al. BLOOD
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
- (2013) Huafeng Xie et al. Cell Stem Cell
- Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
- (2013) Marieta Caganova et al. JOURNAL OF CLINICAL INVESTIGATION
- SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
- (2013) S Jeromin et al. LEUKEMIA
- EZH2 in normal and malignant hematopoiesis
- (2013) K Lund et al. LEUKEMIA
- A20 Restricts Wnt Signaling in Intestinal Epithelial Cells and Suppresses Colon Carcinogenesis
- (2013) Ling Shao et al. PLoS One
- Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex
- (2013) Yoon Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
- (2013) M. Chiorazzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A20 in inflammation and autoimmunity
- (2013) Leen Catrysse et al. TRENDS IN IMMUNOLOGY
- Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1
- (2013) Charusheila Ramkumar et al. Nature Communications
- F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation
- (2012) B. B. Chen et al. BLOOD
- Deletion of the TNFAIP3/A20gene detected by FICTION analysis in classical Hodgkin lymphoma
- (2012) Junko Nomoto et al. BMC CANCER
- Smurf2 Regulates the Senescence Response and Suppresses Tumorigenesis in Mice
- (2012) C. Ramkumar et al. CANCER RESEARCH
- TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes
- (2012) Thorkell Gudjonsson et al. CELL
- EDD induces cell cycle arrest by increasing p53 levels
- (2012) Veronique A.J. Smits CELL CYCLE
- The diverse roles of IRF4 in late germinal center B-cell differentiation
- (2012) Nilushi S. De Silva et al. IMMUNOLOGICAL REVIEWS
- Roles of BCL6 in normal and transformed germinal center B cells
- (2012) Katia Basso et al. IMMUNOLOGICAL REVIEWS
- The coding genome of splenic marginal zone lymphoma: activation ofNOTCH2and other pathways regulating marginal zone development
- (2012) Davide Rossi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Whole-genome sequencing identifies recurrent somaticNOTCH2mutations in splenic marginal zone lymphoma
- (2012) Mark J. Kiel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma
- (2012) Vanesa Fernández-Sáiz et al. NATURE CELL BIOLOGY
- Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
- (2012) Luca Busino et al. NATURE CELL BIOLOGY
- Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
- (2012) Fabiola Traina et al. PLoS One
- SCF-Mediated Degradation of p100 (NF- B2): Mechanisms and Relevance in Multiple Myeloma
- (2012) L. Busino et al. Science Signaling
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)
- (2011) N. Shiba et al. BLOOD
- A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination
- (2011) Vaibhav Kapuria et al. CELLULAR SIGNALLING
- Roles of ubiquitin signaling in transcription regulation
- (2011) Ian Hammond-Martel et al. CELLULAR SIGNALLING
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells
- (2011) E. K. Meziane et al. JOURNAL OF CELL SCIENCE
- Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
- (2011) F C M Braun et al. LEUKEMIA
- A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
- (2011) Apostolos Klinakis et al. NATURE
- FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
- (2011) Shanshan Duan et al. NATURE
- Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
- (2011) Domagoj Vucic et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis
- (2011) Mikhail Lomonosov et al. PLoS One
- SCF ubiquitin ligases in the maintenance of genome stability
- (2011) Joshua S. Silverman et al. TRENDS IN BIOCHEMICAL SCIENCES
- Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
- (2011) Natalia G. Starostina et al. TRENDS IN CELL BIOLOGY
- A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
- (2010) D. Chauhan et al. BLOOD
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
- (2010) Lluis Espinosa et al. CANCER CELL
- Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
- (2010) V. Kapuria et al. CANCER RESEARCH
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome
- (2010) N Shiba et al. LEUKEMIA
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
- (2010) Charlotte M Niemeyer et al. NATURE GENETICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
- (2010) K M Crusio et al. ONCOGENE
- TRAF6 and A20 Regulate Lysine 63-Linked Ubiquitination of Beclin-1 to Control TLR4-Induced Autophagy
- (2010) C. S. Shi et al. Science Signaling
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells
- (2009) K. Basso et al. BLOOD
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
- (2009) W. Ci et al. BLOOD
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
- (2009) M. L. Loh et al. BLOOD
- Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
- (2009) H. Muramatsu et al. BLOOD
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- Ubiquitin-mediated control of oncogene and tumor suppressor gene products
- (2009) Kyoko Kitagawa et al. CANCER SCIENCE
- CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
- (2009) S-C Sun CELL DEATH AND DIFFERENTIATION
- CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
- (2009) Sara A Wickström et al. EMBO JOURNAL
- Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling
- (2009) Patrick W. Blake et al. HUMAN MUTATION
- TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
- (2009) Roland Schmitz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
- (2009) E Chanudet et al. LEUKEMIA
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- Ubiquitination and Degradation of the Inhibitors of NF- B
- (2009) N. Kanarek et al. Cold Spring Harbor Perspectives in Biology
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
- Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
- (2008) E. Rosati et al. BLOOD
- BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
- (2008) Stella M. Ranuncolo et al. BLOOD CELLS MOLECULES AND DISEASES
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Tumor suppressor CYLD: negative regulation of NF-κB signaling and more
- (2008) G. Courtois CELLULAR AND MOLECULAR LIFE SCIENCES
- Function and regulation of protein neddylation. ‘Protein Modifications: Beyond the Usual Suspects’ Review Series
- (2008) Gwénaël Rabut et al. EMBO REPORTS
- Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias
- (2008) S. Abbas et al. HAEMATOLOGICA
- The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration
- (2008) Jinmin Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Some Lessons from My Work on the Biochemistry of the Ubiquitin System
- (2008) Avram Hershko JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer
- (2008) Bruce D. Dorsey et al. JOURNAL OF MEDICINAL CHEMISTRY
- FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias
- (2008) Jee Hoon Song et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started